Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations

Tevogen Bio will receive the remaining $8 million grant, totaling$10 million, from KRHP LLC this quarter, following a positive review of its progress, particularly in Tevogen.AI.Efficient operations with operating expenses of $9.7 million for the first three quarters of 2024.The company's AI division has advanced its PredicTcell platform using expanded datasets and wet lab science to enhance predictive modeling capabilities. WARREN, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio ("Tevogen Bio Holding ...